Home/Filings/4/0001437749-24-005062
4//SEC Filing

Berger Mark Stanley 4

Accession 0001437749-24-005062

CIK 0001595248other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 4:34 PM ET

Size

13.6 KB

Accession

0001437749-24-005062

Insider Transaction Report

Form 4
Period: 2024-02-18
Berger Mark Stanley
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2024-02-18$4.40/sh1,319$5,8044,806 total
Footnotes (2)
  • [F1]Represents shares withheld on February 18, 2024 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan.
  • [F2]This total represents the number of shares of Common Stock beneficially owned following this reported transaction and the 1-for-40 reverse stock split of the Company's Common Stock effected as of February 2, 2024.

Issuer

Genprex, Inc.

CIK 0001595248

Entity typeother

Related Parties

1
  • filerCIK 0001700283

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:34 PM ET
Size
13.6 KB